Answers are grounded in this paper and cite their sources.
BACKGROUND: Diabetic foot disease is a major cause of lower limb amputation (LLA) in low- and middle-income countries (LMICs), where evidence on adjusted risk factors remains limited. This systematic review evaluates the risk factors for LLA and amputation-related mortality in diabetic foot disease across LMICs. METHODS: Embase, MEDLINE, the Cochrane Central Register of Controlled Trials (via Ovid), PubMed, and Scopus were searched from inception to March 2026. Studies of adults with diabetes in LMICs reporting LLA with adjusted effect estimates were included. Pooling of effect estimates was prespecified to require at least three comparable studies per domain. Risk of bias was assessed using the Newcastle-Ottawa Scale or AXIS. RESULTS: Sixteen studies (19,529 participants; 1604 amputation events) provided usable effect estimates; 12 reported adjusted estimates from multivariable models. No domain contained three or more comparable estimates, so quantitative synthesis was not undertaken. Osteomyelitis was independently associated with amputation in both studies assessing it (aOR 5.60, 95% CI 2.93-10.78; aOR 11.8, 95% CI 5.1-27.5). Peripheral arterial disease was associated with LLA in two of three studies using objective vascular assessment (aOR 2.80, 95% CI 1.52-5.11; aOR 3.23 per grade, 95% CI 2.68-3.89). Prior amputation was associated with LLA in two DFU cohorts reporting concordant estimates (aOR 2.86 and 3.08). Ulcer severity was associated with amputation in every study assessing it, using five different classification systems. Prolonged ulcer duration carried an adjusted odds ratio of 10.3 (95% CI 4.06-26.13), and each additional preoperative day was associated with a 9.3% increase in the odds of major amputation. Neuropathy showed no independent association of meaningful size in any adjusted analysis, and HbA1c was not associated in the largest adjusted DFU cohort analysis, although a smaller study with 10 outcome events reported a positive association. CONCLUSION: Peripheral arterial disease, ulcer severity, osteomyelitis, prior amputation, and delayed access to care were associated with LLA in LMIC settings. Neither neuropathy nor HbA1c showed an independent association of meaningful size in adjusted analyses of established DFU cohorts. Prospective LMIC cohorts using standardized definitions are needed.
No takes yet. Share an insight, caveat, or question.
Eteuati et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: